Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Shri Ahimsa Naturals Ltd (SHRIAHIMSA) is currently trading at 386.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Ahimsa Naturals Limited specializes in the extraction and manufacturing of natural caffeine and other herbal extracts. The company has steadily diversified its product line, including launching Green Coffee Bean Extract in 2017-18 and expanding into herbal extracts by 2021. In 2022, Ahimsa began producing crude caffeine from tea and coffee waste, showcasing its commitment to sustainable practices. The company is preparing for an IPO, indicating strategic growth ambitions and plans to enhance its market presence.
Over the past 52 weeks, Shri Ahimsa Naturals Ltd has traded between a low of ₹168.00 and a high of ₹455.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Shri Ahimsa Naturals Ltd has a market capitalization of approximately 904.43. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Shri Ahimsa Naturals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 31.08 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 904.43 Cr, Shri Ahimsa Naturals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Shri Ahimsa Naturals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Shri Ahimsa Naturals Ltd is 31.08. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Investor Presentation
Q4 FY26
Investor Presentation
Q4 FY25
Bearish
4
Neutral
8
Bullish
2
Bearish
14
Neutral
8
Bullish
24
Bearish
10
Neutral
0
Bullish
22
Ahimsa Naturals Limited specializes in the extraction and manufacturing of natural caffeine and other herbal extracts. The company has steadily diversified its product line, including launching Green Coffee Bean Extract in 2017-18 and expanding into herbal extracts by 2021. In 2022, Ahimsa began producing crude caffeine from tea and coffee waste, showcasing its commitment to sustainable practices. The company is preparing for an IPO, indicating strategic growth ambitions and plans to enhance its market presence.
Chemicals & Petrochemicals
Specialty Chemicals
904 Cr
Low Risk
31.1
44.1
—
4.7
455.00
168.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1199.00 | 1,051 Cr | 35.51 | 4.17 | 0.25 | 11.74 | 17.68 | 9.70 | ||
40.80 | 1,006 Cr | 43.11 | 6.49 | 0.00 | 15.03 | 12.76 | 4.61 | ||
774.60 | 958 Cr | 32.23 | 7.96 | 0.19 | 18.60 | 23.77 | 19.27 | ||
132.85 | 954 Cr | 12.02 | 2.43 | 0.38 | 20.22 | 18.45 | 10.16 | ||
750.00 | 945 Cr | 153.06 | 3.59 | 0.00 | 2.36 | 3.43 | 1.41 | ||
179.00 | 926 Cr | 662.96 | 2.06 | 0.00 | 0.32 | 3.17 | 0.22 | ||
386.00 | 904 Cr | 31.08 | 4.68 | 0.00 | 15.06 | 18.76 | 13.33 | ||
| Median: 7 Co. | — | 386.00 | 954 Cr | 35.51 | 4.17 | 0.00 | 15.03 | 17.68 | 9.70 |
